✦ LIBER ✦

Phase III Trial of a Humanized Anti-CD33 Antibody (HuM195) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

✍ Scribed by Gibson, Angelia D.; Tallman, Martin S.; Jain, Vinay K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed or refractory acut

✍ Feldman, E; Kalaycio, M; Weiner, G; Frankel, S; Schulman, P; Schwartzberg, L; Ju 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Phase I studies of AVE9633, an anti-CD33

✍ Simona Lapusan, Maria B. Vidriales, Xavier Thomas, Stephane de Botton, Anne Vekh 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 482 KB

Phase I/II study of humanized anti-CD33

✍ Yukio Kobayashi; Kensei Tobinai; Akihiro Takeshita; Kensuke Naito; Osamu Asai; N 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

398 - Treatment of patients with relapse

✍ E.L. Slevers; I.D. Bernstein; R.T. Spielberger; S.J. Forman; K. Shannon-Dorcy; F 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Phase I study of LY2469298, an Fc-engine

✍ Kensei Tobinai; Michinori Ogura; Yukio Kobayashi; Toshiki Uchida; Takashi Watana 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

A Phase I Trial of Lenalidomide in Combi

✍ Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Brady, William E. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB